Literature DB >> 29127235

Cardiac performance is limited by oxygen delivery to the mitochondria in the crystalloid-perfused working heart.

Sarah Kuzmiak-Glancy1,2, Raúl Covian2, Armel N Femnou1,2, Brian Glancy2, Rafael Jaimes1, Anastasia M Wengrowski1, Kara Garrott1, Stephanie A French2, Robert S Balaban2, Matthew W Kay1.   

Abstract

The left ventricular working, crystalloid-perfused heart is used extensively to evaluate basic cardiac function, pathophysiology, and pharmacology. Crystalloid-perfused hearts may be limited by oxygen delivery, as adding oxygen carriers increases myoglobin oxygenation and improves myocardial function. However, whether decreased myoglobin oxygen saturation impacts oxidative phosphorylation (OxPhos) is unresolved, since myoglobin has a much lower affinity for oxygen than cytochrome c oxidase (COX). In the present study, a laboratory-based synthesis of an affordable perfluorocarbon (PFC) emulsion was developed to increase perfusate oxygen carrying capacity without impeding optical absorbance assessments. In left ventricular working hearts, along with conventional measurements of cardiac function and metabolic rate, myoglobin oxygenation and cytochrome redox state were monitored using a novel transmural illumination approach. Hearts were perfused with Krebs-Henseleit (KH) or KH supplemented with PFC, increasing perfusate oxygen carrying capacity by 3.6-fold. In KH-perfused hearts, myoglobin was deoxygenated, consistent with cytoplasmic hypoxia, and the mitochondrial cytochromes, including COX, exhibited a high reduction state, consistent with OxPhos hypoxia. PFC perfusate increased aortic output from 76 ± 6 to 142 ± 4 ml/min and increased oxygen consumption while also increasing myoglobin oxygenation and oxidizing the mitochondrial cytochromes. These results are consistent with limited delivery of oxygen to OxPhos resulting in an adapted lower cardiac performance with KH. Consistent with this, PFCs increased myocardial oxygenation, and cardiac work was higher over a wider range of perfusate Po2. In summary, heart mitochondria are limited by oxygen delivery with KH; supplementation of KH with PFC reverses mitochondrial hypoxia and improves cardiac performance, creating a more physiological tissue oxygen delivery. NEW & NOTEWORTHY Optical absorbance spectroscopy of intrinsic chromophores reveals that the commonly used crystalloid-perfused working heart is oxygen limited for oxidative phosphorylation and associated cardiac work. Oxygen-carrying perfluorocarbons increase myocardial oxygen delivery and improve cardiac function, providing a more physiological mitochondrial redox state and emphasizing cardiac work is modulated by myocardial oxygen delivery.

Entities:  

Keywords:  cytochrome c oxidase; myoglobin oxygen saturation; oxidative phosphorylation; rabbit; rapid-scanning optical spectroscopy

Mesh:

Substances:

Year:  2017        PMID: 29127235      PMCID: PMC5966767          DOI: 10.1152/ajpheart.00321.2017

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  52 in total

1.  Feedforward sympathetic coronary vasodilation in exercising dogs.

Authors:  M W Gorman; J D Tune; K N Richmond; E O Feigl
Journal:  J Appl Physiol (1985)       Date:  2000-11

2.  Control of maximum rates of glycolysis in rat cardiac muscle.

Authors:  K Kobayashi; J R Neely
Journal:  Circ Res       Date:  1979-02       Impact factor: 17.367

3.  Heterogeneity of the hypoxic state in perfused rat heart.

Authors:  C Steenbergen; G Deleeuw; C Barlow; B Chance; J R Williamson
Journal:  Circ Res       Date:  1977-11       Impact factor: 17.367

4.  Spectroscopic determination of cytochrome c oxidase content in tissues containing myoglobin or hemoglobin.

Authors:  R S Balaban; V K Mootha; A Arai
Journal:  Anal Biochem       Date:  1996-06-01       Impact factor: 3.365

5.  A new, simple method for cold storage of the pancreas using perfluorochemical.

Authors:  Y Kuroda; T Kawamura; Y Suzuki; H Fujiwara; K Yamamoto; Y Saitoh
Journal:  Transplantation       Date:  1988-09       Impact factor: 4.939

6.  Perfluorocarbon emulsions prevent hypoxia of pancreatic β-cells.

Authors:  E Maillard; M T Juszczak; A Langlois; C Kleiss; M C Sencier; W Bietiger; M Sanchez-Dominguez; M P Krafft; P R V Johnson; M Pinget; S Sigrist
Journal:  Cell Transplant       Date:  2011-09-22       Impact factor: 4.064

7.  The erythrocyte-perfused "working heart" model: hemodynamic and metabolic performance in comparison to crystalloid perfused hearts.

Authors:  B K Podesser; S Hallström; H Schima; L Huber; J Weisser; A Kröner; W Fürst; E Wolner
Journal:  J Pharmacol Toxicol Methods       Date:  1999-02       Impact factor: 1.950

8.  Optical measurements of intracellular oxygen concentration of rat heart in vitro.

Authors:  M Tamura; N Oshino; B Chance; I A Silver
Journal:  Arch Biochem Biophys       Date:  1978-11       Impact factor: 4.013

9.  An improved isolated heart preparation for external assessment of myocardial metabolism.

Authors:  S R Bergmann; R E Clark; B E Sobel
Journal:  Am J Physiol       Date:  1979-04

10.  Crystalloid and perfluorochemical perfusates in an isolated working rabbit heart preparation.

Authors:  J M Chemnitius; W Burger; R J Bing
Journal:  Am J Physiol       Date:  1985-08
View more
  13 in total

1.  Optocardiography and Electrophysiology Studies of Ex Vivo Langendorff-perfused Hearts.

Authors:  Luther M Swift; Rafael Jaimes; Damon McCullough; Morgan Burke; Marissa Reilly; Takuya Maeda; Hanyu Zhang; Nobuyuki Ishibashi; Jack M Rogers; Nikki Gillum Posnack
Journal:  J Vis Exp       Date:  2019-11-07       Impact factor: 1.355

2.  Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts.

Authors:  Armel N Femnou; Abigail Giles; Robert S Balaban
Journal:  J Vis Exp       Date:  2019-05-12       Impact factor: 1.355

3.  Perfused murine heart optical transmission spectroscopy using optical catheter and integrating sphere: Effects of ischemia/reperfusion.

Authors:  Tyler M Bauer; Abigail V Giles; Junhui Sun; Armel Femnou; Raul Covian; Elizabeth Murphy; Robert S Balaban
Journal:  Anal Biochem       Date:  2019-09-17       Impact factor: 3.365

4.  Paradoxical arteriole constriction compromises cytosolic and mitochondrial oxygen delivery in the isolated saline-perfused heart.

Authors:  Abigail V Giles; Junhui Sun; Armel N Femnou; Sarah Kuzmiak-Glancy; Joni L Taylor; Raul Covian; Elizabeth Murphy; Robert S Balaban
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-10-12       Impact factor: 4.733

5.  A metabocentric view of cardiac remodeling.

Authors:  Bradford G Hill
Journal:  Curr Opin Physiol       Date:  2019-04-15

Review 6.  Stop the beat to see the rhythm: excitation-contraction uncoupling in cardiac research.

Authors:  Luther M Swift; Matthew W Kay; Crystal M Ripplinger; Nikki Gillum Posnack
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-10-08       Impact factor: 4.733

7.  Microfluidics-enabled 96-well perfusion system for high-throughput tissue engineering and long-term all-optical electrophysiology.

Authors:  Lai Wei; Weizhen Li; Emilia Entcheva; Zhenyu Li
Journal:  Lab Chip       Date:  2020-09-30       Impact factor: 6.799

Review 8.  Energy metabolism design of the striated muscle cell.

Authors:  Brian Glancy; Robert S Balaban
Journal:  Physiol Rev       Date:  2021-03-18       Impact factor: 46.500

9.  High-Resolution Optical Measurement of Cardiac Restitution, Contraction, and Fibrillation Dynamics in Beating vs. Blebbistatin-Uncoupled Isolated Rabbit Hearts.

Authors:  Vineesh Kappadan; Saba Telele; Ilija Uzelac; Flavio Fenton; Ulrich Parlitz; Stefan Luther; Jan Christoph
Journal:  Front Physiol       Date:  2020-05-26       Impact factor: 4.566

10.  Isolated perfused working hearts provide valuable additional information during phenotypic assessment of the diabetic mouse heart.

Authors:  Tina M Pedersen; Neoma T Boardman; Anne D Hafstad; Ellen Aasum
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.